Identifies themes and clusters of stock movements
Market TodayThemes and Stocks AnalysesThematic Stock SearchClick here for daily refresh schedule
MBOT - Microbot Medical, Inc.
-0.15(-2.02%)8:32:44 PM 11/23/2020
Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Stock Chart
No summary

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics

Related Peers

Stock news

    Microbot Medical Secures Patents in Multiple Global Jurisdictions

    HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company’s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued/allowed patents and 23 patent applications pending worldwide. “As we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achievin...

    Microbot Medical to Highlight Progress and Recent Achievements at H.C. Wainwright 6th Annual Israel Conference

    Webcast to be Held on Thursday November 12th at 2:00pm ET HINGHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that Harel Gadot, the Company’s CEO, President and Chairman, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright 6th Annual Israel Conference, on November 12, 2020 at 2:00pm ET. In addition to the presentation, the conference will feature virtual one-on-one meetings with Microbot Me...

    Microbot Medical Receives Notice of Allowance for U.S. Patent Covering a System for Reducing Dialysis Shunt Stenosis

    HINGHAM, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 15/592,227, which pertains to a device for reducing dialysis shunt stenosis. The allowed patent application is a Continuation of Patent No. 9,675,748, which was issued on June 13, 2017. “This latest patent allowance demonstrates the continued solid execution of our IP portfolio stra...

    Microbot Medical Schedules Virtual Meeting to Address Increased Interest Following its Recent Announcement

    Webinar to be Held on Wednesday August 26th at 11am ETHINGHAM, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Following its participation at the Needham Virtual Med Tech & Diagnostic conference, as well as the overwhelming interest generated since its recent announcement which included the outcome of a feasibility animal study with respect to the LIBERTYTM Robotic System, Microbot Medical Inc. (Nasdaq: MBOT) will host a webinar on Wednesday, August 26, 2020 at 11:00am ET.  Harel Gadot, the Company’s C...

    Microbot Medical Announces Successful Animal Study Utilizing Its LIBERTY™ Robotic System

    LIBERTY™ Robotic System being remotely operated LIBERTY™ Robotic System being remotely operated LIBERTY™ Robotic System LIBERTY™ Robotic SystemWorld’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse Events Remotely Performed Procedures have the Potential to Reduce Radiation Exposure, Physical Strain and Cross Contamination to Both the Patients and the Surgical StaffHINGHAM, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT),...

    Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System

    Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics ConferenceHINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System. Harel Gadot, CEO, President and Chairman along with other members of the management team are sched...

    Microbot Medical Appoints the Co-Founder of Corindus Vascular Robotics to its Board of Directors

    Vascular Interventions Executive Will Contribute Significantly to the Development and Commercialization of LIBERTY Robotic SystemHINGHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and expertise as Mr. Tal Wenderow, an experienced medical device and robotics executive with a proven track record in small and mid-size companies, has been appointed to the Company's Board of Directors.  Mr. Wenderow co-founded...

    Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...